HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamide

inhibits Bcl-2 family proteins; structure in first source
Also Known As:
BI 97C1; BI-97C1; Sabutoclax
Networked: 14 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pellecchia, Maurizio: 7 articles (06/2015 - 05/2010)
2. Dash, Rupesh: 6 articles (06/2015 - 05/2010)
3. Fisher, Paul B: 6 articles (06/2015 - 05/2010)
4. Das, Swadesh K: 5 articles (06/2015 - 05/2011)
5. Quinn, Bridget A: 5 articles (06/2015 - 05/2011)
6. Sarkar, Devanand: 5 articles (06/2015 - 05/2011)
7. Wei, Jun: 5 articles (06/2015 - 05/2010)
8. Reed, John C: 5 articles (11/2012 - 05/2010)
9. Azab, Belal: 3 articles (06/2015 - 05/2011)
10. Sarkar, Siddik: 3 articles (06/2015 - 05/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)
3. Breast Neoplasms (Breast Cancer)
4. Adenocarcinoma
5. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. 1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamide
2. apogossypol
3. AD 5
4. Proteins (Proteins, Gene)
5. Carcinogens
6. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
7. Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
8. Caspases
9. Staurosporine
10. Minocycline (Cyclops)

Related Therapies and Procedures

1. Nanospheres
2. Therapeutics
3. Drug Therapy (Chemotherapy)